Exports of Medicines Temporarily Suspended to Ensure National Supply
The National Medicines and Health Products Authority (Infarmed) has updated the list of medicines whose export is temporarily banned. The new version includes eight more drugs than the previous month’s and covers essential medicines used to treat heart failure, osteoporosis, psychiatric disorders (antipsychotics), pain (analgesics) and bacterial infections (antibiotics).
European Commission Presents Critical Medicines Act
On March 12, 2025, the European Commission took an important step in strengthening the European Union’s strategic autonomy with regard to the availability of essential medicines. It presented the Critical Medicines Act, a new initiative aimed at guaranteeing continuous access to essential medicines, preventing shortages and improving the resilience of supply chains in the pharmaceutical industry.
Update on Prior Notification of Medicines Transactions Abroad
On March 11, 2025, Information Circular No. 022/CD/100.20.200 was published, bringing important updates on the export of medicines.
New Rules for Medicine Export Control in Portugal
INFARMED has introduced stricter export controls to prevent medicine shortages. Wholesale distributors must report exports, while manufacturers and pharmacies face less bureaucracy. These measures align with EU regulations, ensuring transparency and protecting national supply.